文献

J-GLOBAL ID：201402267161597684   整理番号：14A0272021

耐性変異HIVウイルスの広範囲に対し強力で経口投与可能な非ヌクレオシド逆転写酵素阻害剤,MK-1439の発見

Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses

著者 (37件)： COTE Bernard (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  BURCH Jason D. (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  ASANTE-APPIAH Ernest (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  BAYLY Chris (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  BEDARD Leanne (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  BLOUIN Marc (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  CAMPEAU Louis-Charles (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  CAUCHON Elizabeth (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  CHAN Manuel (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  CHEFSON Amandine (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  COULOMBE Nathalie (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  CROMLISH Wanda (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  DEBNATH Smita (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  DESCHENES Denis (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  DUPONT-GAUDET Kristina (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  FALGUEYRET Jean-Pierre (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  FORGET Robert (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  GAGNE Sebastien (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  GAUVREAU Danny (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  GIRARDIN Melina (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  GUIRAL Sebastien (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  LANGLOIS Eric (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  LI Chun Sing (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  NGUYEN Natalie (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  PAPP Rob (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  PLAMONDON Serge (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  ROY Amelie (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  ROY Stephanie (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  SELINIOTAKIS Ria (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  ST-ONGE Miguel (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  OUELLET Stephane (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  TAWA Paul (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  TRUCHON Jean-Francois (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  VACCA Joe (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  WRONA Marc (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  DUCHARME Yves (Merck Frosst Centre for Therapeutic Res., QC, CAN) ,  YAN Youwei (Merck Res. Lab., PA, USA)
資料名： Bioorganic & Medicinal Chemistry Letters  (Bioorganic & Medicinal Chemistry Letters)
巻： 24  号： 3  ページ： 917-922  発行年： 2014年 
JST資料番号： W0248A  ISSN： 0960-894X  資料種別： 逐次刊行物 (A)
発行国： オランダ (NLD)  言語： 英語 (EN)

タイトルに関連する用語 (6件)： 耐性変異 ,  HIV ,  ウイルス ,  経口投与 ,  ヌクレオシド逆転写酵素阻害剤 ,  発見